Woman in Cancer Remission for Record 19 Years After CAR-T Immune Treatment
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Del Bufalo F, De Angelis B, Caruana I, Del Baldo G, De Ioris M, Serra A
. GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. N Engl J Med. 2023; 388(14):1284-1295.
DOI: 10.1056/NEJMoa2210859.
View